When treating patients with immune checkpoint inhibitors, do you routinely check markers of endocrinopathies such as TSH/ACTH, or only when a patient has symptoms?

Topics: Lung Cancer • Melanoma/Skin Cancer • Pediatric Oncology • Thoracic Malignancies • Medical Oncology • Biologic Therapy/Immunobiology • Endocrinology

If so, how often do you check these labs?

Answer from: Medical Oncologist at Community Practice

There are clearly defined parameters for routine monitoring that are outlined in the NCCN guidelines. We have incorporated these into our treatment plans. https://www.nccn.org/professionals/physician_gls/pdf/immunotherapy.pdf

Comments

Medical Oncologist at Stamford Hospital
Agree with the above from my grade school colleagu...

Related Questions